Free exclusive webinar on ‘Multiscale and multi-modal insights into drug formulation’ – Join the experts! Read more
BeiGene Announces Acceptance of a Supplemental Biologics License Application in China for Tislelizumab in Nasopharyngeal Cancer Read more
FDA Approves Opdivo (nivolumab) for the Adjuvant Treatment of Patients with High-Risk Urothelial Carcinoma Read more
Bristol Myers Squibb Receives European Commission Approval for Abecma (Idecabtagene Vicleucel) Read more
PerkinElmer Expands Automated Mycotoxin Detection Kits Portfolio to Include All Major Mycotoxins Read more
Sorrento Announces Its Lead Protein-Based COVID-19 Vaccine Candidate – DYAI-100 – Elicits Strong Neutralizing Immune Responses in Vaccinated Animals Against SARS-CoV-2 and Multiple Major Variants of Concern Read more